Nocturnal Weakly Acidic Reflux Promotes Aspiration of Bile Acids in Lung Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 28, Issue 2, 2009, Pages 141-148

  Blondeau, Kathleen ^a   Mertens, Veerle ^a   Vanaudenaerde, Bart A ^b   Verleden, Geert M ^b   Van Raemdonck, Dirk E ^b   Sifrim, Daniel ^a   Dupont, Lieven J ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID;

ACID ASPIRATION; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYMATIC ASSAY; GASTROESOPHAGEAL REFLUX; GRAFT RECIPIENT; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; PH MEASUREMENT; PRIORITY JOURNAL; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; ADULT; AGED; BILE ACIDS AND SALTS; BRONCHIOLITIS OBLITERANS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 59349114512     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.11.906     Document Type: Article

References (27)

1. Benden C., Aurora P., Curry J., et al. High prevalence of gastroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 40 (2005) 68-71
2. Hadjiliadis D., Duane Davis R., Steele M.P., et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 17 (2003) 363-368
3. D'Ovidio F., Mura M., Tsang M., et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 129 (2005) 1144-1152
4. Ward C., Forrest I.A., Brownlee I.A., et al. Pepsin-like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 60 (2005) 872-874
5. D'Ovidio F., Mura M., Ridsdale R., et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 6 (2006) 1930-1938
6. Cantu E., Appel J.Z., Hartwig M.G., et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 78 (2004) 1142-1151
7. Davis R.D., Lau C.L., Eubanks S., et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 125 (2003) 533-542
8. Palmer S.M., Miralles A.P., Howell D.N., et al. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 118 (2000) 1214-1217
9. Blondeau K., Mertens V., Vanaudenaerde B., et al. Acid, non-acid GER and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 31 (2008) 707-713
10. Fornari F., Blondeau K., Tack J., and Sifrim D. Nocturnal gastroesophageal reflux (NGER) revisited with impedance-pH monitoring. Gastroenterology 132 (2007) A280
11. Sifrim D., and Blondeau K. Technology insight: the role of impedance testing for esophageal disorders. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 210-219
12. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
13. Sifrim D., Castell D., Dent J., and Kahrilas P.J. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53 (2004) 1024-1031
14. Zerbib F., des Varannes S.B., Roman S., et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 22 (2005) 1011-1021
15. Boehler A., Kesten S., Weder W., and Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 114 (1998) 1411-1426
16. Verleden G.M., Bankier A., Boehler A., Corris P., and Dupont L.J. Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment. Eur Respir Monogr 29 (2004) 1-25
17. Young L.R., Hadjiliadis D., Davis R.D., and Palmer S.M. Lung transplantation exacerbates gastroesophageal reflux disease. Chest 124 (2003) 1689-1693
18. Halsey K.D., Wald A., Meyer K.C., Torrealba J.R., and Gaumnitz E.A. Non-acidic supraesophageal reflux associated with diffuse alveolar damage and allograft dysfunction after lung transplantation: a case report. J Heart Lung Transplant 27 (2008) 564-567
19. Button B.M., Roberts S., Kotsimbos T.C., et al. Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J Heart Lung Transplant 24 (2005) 1522-1529
20. Pasricha P.J. Effect of sleep on gastroesophageal physiology and airway protective mechanisms. Am J Med 115 suppl 3A (2003) 114S-118S
21. Fass R., Achem S.R., Harding S., Mittal R.K., and Quigley E. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux. Aliment Pharmacol Ther 20 suppl 9 (2004) 26-38
22. Gotley D.C., Morgan A.P., Ball D., Owen R.W., and Cooper M.J. Composition of gastro-oesophageal refluxate. Gut 32 (1991) 1093-1099
23. Scarpulla G., Camilleri S., Galante P., Manganaro M., and Fox M. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 102 (2007) 2642-2647
24. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55 (2006) 1398-1402
25. McCallum R.W. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. Gastroenterol Clin N Am 19 (1990) 551-564
26. Koek G.H., Sifrim D., Lerut T., Janssens J., and Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52 (2003) 1397-1402
27. Wise J., and Conklin J.L. Gastroesophageal reflux disease and baclofen: is there a light at the end of the tunnel?. Curr Gastroenterol Rep 6 (2004) 213-219